Improved glucose clearance reduces blood sugar spikes, easing the demand on insulin and supporting healthier post-meal GLP-1 signaling
Vitamin B12 deficiency is particularly relevant, as many people with diabetes also take metformin, which the MHRA has identified as reducing vitamin B12 levels with long-term use
The primary differentiator is the GLP-1 ID individualized dosing protocol
Here is what the clinical evidence shows: Key sources: Weight loss is typically fastest in the first 36 months and then plateaus
The best results occur in patients with good general health, scalp health, and hair quality in the donor area, and who have reasonable expectations (True 2021)
Common side effects include blue or green discoloration of urine, which almost everyone will notice due to the dye property of the drug